News Medical: Vaccinia virus-based vaccines mount a robust immune response against the monkeypox virus
New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the monkeypox virus observed in the current outbreak (MPXV-2022). Since the ...
Vaccinia virus-based vaccines mount a robust immune response against the monkeypox virus
News Medical: Study of natural killer lymphocytes transcriptionally reprogrammed by vaccinia virus
In a recent study posted to the bioRxiv* preprint server, researchers evaluated responses of natural killer (NK) lymphocytes to VACV (vaccinia virus) infections in vivo. Studies have reported that NK ...
News Medical: Engineering safe and effective vaccinia virus vectors for next-generation vaccines
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...
New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the monkeypox virus observed in the current outbreak (MPXV-2022). New ...
News Medical: Impact of vaccinia virus-based vaccines on the 2022 monkeypox virus outbreak
Science Daily: Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows
Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows
The Conversation: COVID‑19 vaccines produce T‑cell immunity that lasts and works against virus variants
Over the past year or so, ordinary people have learnt a lot about viruses, vaccines and the immune system. We have all had to digest a lot of complex specialist knowledge about how safe and effective ...
COVID‑19 vaccines produce T‑cell immunity that lasts and works against virus variants